Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Charlotte Schmidt-Hieber"'
Autor:
Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Publikováno v:
Clinical Hematology International, Vol 4, Iss 3, Pp 65-74 (2022)
Abstract The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients w
Externí odkaz:
https://doaj.org/article/a1c7626872d6438d82dd956185a4915a
Autor:
Hannah Moatti, Marie-Céleste Laroque, Loïc. Renaud, Odonchimeg Ravdan, Charlotte Schmidt-Hieber, Isabelle Madelaine, Roberta Di Blasi, Catherine Thieblemont, Pauline Brice
Publikováno v:
HemaSphere, Vol 6, Pp 51-51 (2022)
Externí odkaz:
https://doaj.org/article/90b99f7c342343a48c506d6de00e8b8b
Autor:
Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Publikováno v:
Clinical hematology international. 4(3)
The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients were mostl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7d9d74dc6ea45c2c101ee7a4d57124
https://pubmed.ncbi.nlm.nih.gov/36103041
https://pubmed.ncbi.nlm.nih.gov/36103041